Mesenchymal stem cell (MSc) secretome: A possible therapeutic strategy for intensive-care COVID-19 patients

As an emerging global health challenge, COVID-19 requires international knowledge to reach novel possible therapeutic strategies, especially for intensive-care patients. During the early stages of infection, pneumocytes II are the primary infected cells, harming the respiratory system. We have previ...

Descripción completa

Detalles Bibliográficos
Autores principales: Deffune, Elenice, Prudenciatti, Aruã, Moroz, Andrei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7252028/
https://www.ncbi.nlm.nih.gov/pubmed/32371362
http://dx.doi.org/10.1016/j.mehy.2020.109769

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7252028/
https://www.ncbi.nlm.nih.gov/pubmed/32371362
http://dx.doi.org/10.1016/j.mehy.2020.109769

Ejemplares similares